Found 7 matching trials
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
PHASE1Background:
* Malignant mesothelioma is a form of cancer that develops on ...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
PHASE1Background:
* Advanced cases of non-small-cell lung carcinoma (NSCLC) usua...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses
PHASE1Although Neopharm has terminated its sponsorship of this study, it is conti...
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
PHASE1RATIONALE: Immunotoxins can locate tumor cells and kill them without harmin...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma
PHASE1Background:
Standard therapy for mesothelioma is a combination of the drug...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days
PHASE1Although Neopharm has terminated its sponsorship of this study, it is conti...
Immunotoxin Therapy in Treating Patients With Advanced Cancer
PHASE1RATIONALE: Immunotoxins can locate tumor cells and kill them without harmin...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support